InvestorsHub Logo
Followers 1053
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: Penny Masters post# 6865

Friday, 10/28/2016 1:18:58 PM

Friday, October 28, 2016 1:18:58 PM

Post# of 83348
Sayin again, CVSI has one of the highest revenue numbers in the weed sector.Market cap hasn't reflected that fact yet. half revenues than GWPH 2.5b co.!! CVSI has also most solid balance sheet. Assets/Liabilities ratio of 5.5, very rare.

another Comparison to many I did recently:
CBDS ran from .3 to 6 and has only 65k revenues (6 months), CVSI has 5m revenues so far, trading 1/3 it's cap.

The CBD Report mentioned only a few leading companies including GW Pharmaceuticals ( NASDAQ : GWPH ), Insys Therapeutics, CV Sciences ( OTCQB : CVSI ), Bluebird Botanicals, Atalo Holdings, CW Hemp, http://finance.yahoo.com/news/report-u-cbd-sales-reach-130000607.html

GWPH's Market cap over $2.5B and posted only $3M revenues for 3 months ended June 30.

GWPH mentioned on their 10Q that: "GS has significant and increasing liquidity needs and may require additional funding"

CVSI "The Company has sufficient cash reserves and access to capital to meet its working capital requirements. Stockholders’ equity amounted to
approximately $21.8 million as of June 30, 2016".





My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.